Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Cardiology
|
January 1, 1994
[The prevention of nitrate tolerance in angina patients treated with transdermal nitroglycerin: a comparison of 2 therapeutic regimens (therapeutic outlook versus dosage reduction)]
E Adornato, A Cecchi, C Cinelli, et al.
Clinical Rheumatology
|
October 12, 2012
Bosentan fosters microvascular de-remodelling in systemic sclerosis
S Guiducci, S Bellando Randone, C Bruni, et al.
Cardiologia (Rome, Italy)
|
December 31, 2002
[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)]
A Maresta, M Balducelli, E Varani, et al.
Clinical Trials and Meta-Analysis
|
March 9, 1994
The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population
A Maresta, M Balducelli, L Cantini, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 1, 1993
Effect of steroid eluting versus conventional electrodes on propafenone induced rise in chronic ventricular pacing threshold
D Cornacchia, M Fabbri, A Maresta, et al.
Minerva Cardioangiologica
|
May 31, 2007
Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial
M Balducelli, E Varani, G Vecchi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 24, 1999
One-year outcome in multivessel coronary disease patients undergoing coronary stenting
S De Servi, G Mariani, I Bossi, et al.
Circulation
|
December 1, 1994
Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica
A Maresta, M Balducelli, L Cantini, et al.
Giornale Italiano Di Cardiologia
|
July 1, 1997
Coronary restenosis after optimal (stent-like) initial angiographic results obtained by traditional balloon angioplasty
V Di Luzio, F De Remigis, G De Curtis, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 1, 1997
Steroid-eluting electrodes prevent chronic pacing threshold rise in the atrial chamber after oral propafenone administration
D Cornacchia, M Fabbri, A Maresta, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Cardiology
|
January 1, 1994
[The prevention of nitrate tolerance in angina patients treated with transdermal nitroglycerin: a comparison of 2 therapeutic regimens (therapeutic outlook versus dosage reduction)]
E Adornato, A Cecchi, C Cinelli, et al.
Clinical Rheumatology
|
October 12, 2012
Bosentan fosters microvascular de-remodelling in systemic sclerosis
S Guiducci, S Bellando Randone, C Bruni, et al.
Cardiologia (Rome, Italy)
|
December 31, 2002
[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)]
A Maresta, M Balducelli, E Varani, et al.
Clinical Trials and Meta-Analysis
|
March 9, 1994
The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population
A Maresta, M Balducelli, L Cantini, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 1, 1993
Effect of steroid eluting versus conventional electrodes on propafenone induced rise in chronic ventricular pacing threshold
D Cornacchia, M Fabbri, A Maresta, et al.
Minerva Cardioangiologica
|
May 31, 2007
Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial
M Balducelli, E Varani, G Vecchi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 24, 1999
One-year outcome in multivessel coronary disease patients undergoing coronary stenting
S De Servi, G Mariani, I Bossi, et al.
Circulation
|
December 1, 1994
Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica
A Maresta, M Balducelli, L Cantini, et al.
Giornale Italiano Di Cardiologia
|
July 1, 1997
Coronary restenosis after optimal (stent-like) initial angiographic results obtained by traditional balloon angioplasty
V Di Luzio, F De Remigis, G De Curtis, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 1, 1997
Steroid-eluting electrodes prevent chronic pacing threshold rise in the atrial chamber after oral propafenone administration
D Cornacchia, M Fabbri, A Maresta, et al.
Page
of 10